Myriad Genetics | MYGN - Vertriebs- Und Verwaltungskosten

Aktienkurs
5.08
Täglich Wechseln
0.08 1.60%
Monatlich
9.48%
Jährlich
-31.35%
Q2 Prognose
4.23




Vertriebs- Und Verwaltungskosten Veränderung Datum
Agilent USD 476M 48M 2025-12
Becton, Dickinson and Co. USD 1.39B 27M 2025-12
Bio-Rad Laboratories USD 206.8M 900K 2025-09
Bruker USD 247.2M 4.7M 2025-12
Danaher USD 2.03B 35M 2025-12
Illumina USD 283M 27M 2025-12
J&J USD 6.03B 719M 2026-03
Mettler Toledo International USD 259.83M 11.43M 2025-12
Myriad Genetics USD 122.3M 6.7M 2025-12
OraSure Technologies USD 13.21M 3.29M 2025-12
Pacific Biosciences Of California USD 37.24M 25.68M 2025-12
Quest Diagnostics USD 504M 3M 2025-12
Quidel USD 194.4M 7.5M 2025-12
Repligen USD 74.36M 703K 2025-12
Revvity USD 251.73M 9.82M 2025-12
Standard Biotools USD 21.55M 5.05M 2025-12
Thermo Fisher Scientific USD 1.98B 182M 2025-12
Veracyte USD 43.31M 8.43M 2025-12
Waters USD 240.01M 25.78M 2025-12